The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Flutamide, Testolactone, and Reduced Hydrocortisone Dose Maintain Normal Growth Velocity and Bone Maturation Despite Elevated Androgen Levels in Children with Congenital Adrenal Hyperplasia
Abstract
Treatment outcome in congenital adrenal hyperplasia is often sub-optimal due to hyperandrogenism, treatment-induced hypercortisolism, or both. We previously reported better control of linear growth, weight gain, and bone maturation in a short term cross-over study of a new four-drug treatment regimen containing an antiandrogen (flutamide), an inhibitor of androgen to estrogen conversion (testolactone), reduced hydrocortisone dose, and fludrocortisone, compared to the effects of a control regimen of hydrocortisone and fludrocortisone. Twenty-eight children have completed 2 yr of follow-up in a subsequent long term randomized parallel study comparing these two treatment regimens. During 2 yr of therapy, compared to children receiving hydrocortisone, and fludrocortisone treatment, children receiving flutamide, testolactone, reduced hydrocortisone dose (average of 8.7 +/- 0.6 mg/m2 x day), and fludrocortisone had significantly (P < or = 0.05) higher plasma 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone, dehydroepiandrosterone sulfate, and testosterone levels. Despite elevated androgen levels, children receiving the new treatment regimen had normal linear growth rate (at 2 yr, 0.1 +/- 0.5 SD units), and bone maturation (at 2 yr, 0.7 +/- 0.3 yr bone age/yr chronological age). No significant adverse effects were observed after 2 yr. We conclude that the regimen of flutamide, testolactone, reduced hydrocortisone dose, and fludrocortisone provides effective control of congenital adrenal hyperplasia with reduced risk of glucocorticoid excess. A long term study of this new regimen is ongoing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This was studied in 28 prepubertal children with classic 21OH deficiency using an anti-androgen and aromatase-inhibitor in combination with lower dose hydrocortisone and fludrocortisone, and was successful in normalizing growth over 2 years.144”
From Congenital adrenal hyperplasia (2017) · cites this paper as [144]
In the citing paper
“In a 2-year randomized, parallel study, children with classic CAH (n = 28) receiving low dose hydrocortisone and fludrocortisone combined with the experimental regimen of flutamide (an anti-androgen) and testolactone (an aromatase inhibitor) maintained normal growth velocity and skeletal maturation despite elevations in adrenal androgens14.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [14]
In the citing paper
“In a 2-year randomized parallel study of 28 children, patients receiving the experimental four-drug regimen had normal growth and bone maturation, despite elevated adrenal steroids (315).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [315]
Citations
Cites
Tanner, J. M. (1978) · Medical Entomology and Zoology · Cited by 3,742
Tanner, J. M., Whitehouse, R. H., & Takaishi, M. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.220.613 · Cited by 2,549
Congenital Adrenal Hyperplasia
Speiser, P., & White, P. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,420
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Clinical longitudinal standards for height and height velocity for North American children
Tanner, J. M., & Davies, P. S. W. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80501-1 · Cited by 1,088
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Anthropometric reference data and prevalence of overweight, United States, 1976-80.
Najjar, M. F., & Rowland, M. (1987) · PubMed · Cited by 521
Zhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Testicular volume during adolescence. Cross-sectional and longitudinal studies.
ZACHMANN, M., Prader, A., Kind, H. P., Häfliger, H., & Budliger, H. (1974) · PubMed · Cited by 440
Cited by
Sorted by citations
Items 101–190 of 190
Dagalakis, U., Mallappa, A., Elman, M., Quezado, M., & Merke, D. P. (2016) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-016-0028-4 · Cited by 10
Self-citationMedical treatment of classic and nonclassic congenital adrenal hyperplasia
Speiser, P. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_9 · Cited by 10
Puberty and Its Disorders in the Male
Palmert, M. R., Chan, Y.-M., & Dunkel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00018-x · Cited by 10
de Lemos‐Marini, S. H. V., Guerra‐Júnior, G., Morcillo, A. M., Baptista, M. T. M., Silva, L. O., & Maciel‐Guerra, A. T. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000600008 · Cited by 10
Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors
Vaid, S., Kulkarni, S., Marko, J., Sinaii, N., Sukin, C., Burkardt, D. D., Eustace, Q., Mallappa, A., & Merke, D. P. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf498 · Cited by 10
Self-citationShaikh, A. M. A., Alghanmi., Y., Awidah, S., Bahha, A., Ahmed, M., & Soliman, A. T. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_99_19 · Cited by 9
Congenital Adrenal Hyperplasia: From Genetics and Biochemistry to Clinical Practice, Part 2
Collett‐Solberg, P. F. (2001) · Clinical Pediatrics · doi:10.1177/000992280104000301 · Cited by 9
Treatment of Short Stature with Aromatase Inhibitors: A Systematic Review and Meta-Analysis
Liu, J., Yin, S., Luo, Y., Bai, X., Chen, S., Yang, H., Zhu, H., Pan, H., & Ma, H. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1492-2841 · Cited by 8
Novel Basic and Clinical Aspects of Congenital Adrenal Hyperplasia
Merke, D. P., & Camacho, C. A. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011520600476 · Cited by 8
Self-citationCurrent Advances in the Management of Congenital Adrenal Hyperplasia
Bouliari, A., Bullard, F., Lin‐Su, K., & Lekarev, O. (2024) · Advances in Pediatrics · doi:10.1016/j.yapd.2024.02.006 · Cited by 7
Kendırcı, H. N. P., Ünal, E., Dündar, İ., Buluş, A. D., Güneş, S. O., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-26-s · Cited by 9
Auchus, R. J., Courtillot, C., Dobs, A. S., El‐Maouche, D., Falhammar, H., Lacroix, A., Farrar, M., O’Donoghue, C., Anatchkova, M., Cutts, K. N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1005963 · Cited by 7
van Gool, S. A., Wit, J. M., Schutter, T. M. D., Clerck, N. D., Postnov, A., Hovinga, S. K., van Doorn, J., Veiga, S. J., García‐Segura, L. M., & Karperien, M. (2010) · Hormone Research in Paediatrics · doi:10.1159/000271916 · Cited by 8
Restoration of Height after 11 Years of Letrozole Treatment in 11β-Hydroxylase Deficiency
Atay, Z., Turan, S., Buğdaycı, O., Güran, T., & Bereket, A. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501456 · Cited by 7
Emerging treatment for congenital adrenal hyperplasia
White, P. C. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000723 · Cited by 7
Charmandari, E., Johnston, A. E., Honour, J. W., Brook, C. G. D., & Hindmarsh, P. C. (2002) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2002.15.4.435 · Cited by 7
Nimkarn, S., New, M. I., & Lin-Su, K. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.8.883 · Cited by 29
Ahmed, S. E. A. M., Soliman, A. T., Ramadan, M. A. E. F., Elawwa, A., Abugabal, A. M. S., Emam, M. H. A., & Sanctis, V. D. (2019) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v90i3.8732 · Cited by 6
Liu, X., Liu, F., Qi, Y., Han, X., Ma, S., & Zheng, R. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05703-8 · Cited by 5
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_14 · Cited by 7
Tratamento da hiperplasia supra-renal congênita por deficiência da 21-hidroxilase
Bachega, T. A. S. S., Madureira, G., Brenlha, E. M. L., Ueti, R. C., Inácio, M., Dènis, F. T., Silva, F. A. Q., Arnhold, I. J. P., & Mendonca, B. B. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000100010 · Cited by 5
Aromatase inhibitors for short stature in male children and adolescents
McGrath, N., & O'Grady, M. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010888 · Cited by 5
Blocs enzymatiques précoces de la surrénale
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Polak, M., & Touraine, P. A. (2008) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(08)40173-7 · Cited by 4
Metabolic and endocrine disorders
Hawdon, J. M., Cheetham, T. D., Schenk, D. J., Wraith, J. E., Jones, S. A., & Bishop, N. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3479-4.00035-0 · Cited by 4
Classic Congenital Adrenal Hyperplasia
Charmandari, E., Chrousos, G. P., & Merke, D. P. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_10 · Cited by 4
Self-citationHyperplasie congénitale des surrénales: les formes précoces
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Touraine, P. A., & Polak, M. (2009) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(09)72438-x · Cited by 4
A Narrative Review of Flutamide in Juvenile Nasopharyngeal Angiofibroma
Lim, A. E., Hurley, R., Slim, M. A. M., & Melia, L. (2023) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-023-03581-z · Cited by 3
Silva, I. N., Cunha, C. F., Antônio, S. D., & Andrade, G. F. M. P. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000100016 · Cited by 3
Déficit de 21-hidroxilasa: aspectos actuales
Rodriguez-Arnao, M. D., Rodríguez, A., Badillo, K., Velasco, A. M., Dulín, E., & Ezquieta, B. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71078-6 · Cited by 3
Diagnosis and management of congenital adrenal hyperplasia
Speiser, P. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.103 · Cited by 3
Congenital Adrenal Hyperplasia
Bhansali, A., Aggarwal, A., Parthan, G., & Gogate, Y. (2016) · Clinical Rounds in Endocrinology · doi:10.1007/978-81-322-2815-8_10 · Cited by 2
Hiperplasia suprarrenal congénita: diagnóstico, tratamiento y evolución a largo plazo
Labarta, J. I., Bello, E., Ferrández, A., & Mayayo, E. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74628-8 · Cited by 2
Approach to the Child and Adolescent With Adrenal Insufficiency
Patti, G., Zucconi, A., Matarese, S., Tedesco, C., Panciroli, M., Napoli, F., Iorgi, N. D., & Maghnie, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae564 · Cited by 3
AvRuskin, T. W., Witchel, S. F., Taha, D. R., & JUAN, C. S. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.4.565 · Cited by 2
Inhibidores de la aromatasa: ¿pueden mejorar el crecimiento esquelético?
Audı́, L. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)71403-2 · Cited by 2
Bello, E., Ruiz-Echarri, M., Rueda, C. F., Martul, P., Mayayo, E., & Longás, Á. F. (2016) · Cited by 2
Wang, Q., Zhang, S., Ma, X., Li, G., Wang, Z., & Wang, F. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.04.04 · Cited by 2
Congenital Adrenal Hyperplasia
Levine, L. S., Oberfield, S. E., & Antler, L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_12 · Cited by 2
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_59 · Cited by 2
Fatores que podem predizer a estatura final na deficiência da 21-hidroxilase
Bachega, T. A. S. S. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000600003 · Cited by 2
Congenital Adrenal Hyperplasia and Growth Outcomes
Sharma, R. (2019) · The Indian Journal of Pediatrics · doi:10.1007/s12098-018-2841-7 · Cited by 2
Clinical practice guidelines "Congenital adrenal hyperplasia in children" with comments
Чугунов, І., Kopylova, I., Kolodkina, A. A., Kalinchenko, N. Y., Vorontsova, M. V., Bezlepkina, O. B., Peterkova, V. A., & Mokrysheva, N. G. (2026) · Problems of Endocrinology · doi:10.14341/probl13767 · Cited by 1
Disorders of Steroid Synthesis and Metabolism
Biason‐Lauber, A. (2006) · Springer eBooks · doi:10.1007/3-540-28962-3_31 · Cited by 1
Clinical applications of molecular genetics: the model of congenital adrenal hyperplasia.
Loke, K. Y. (2008) · PubMed · Cited by 1
Nordenstrom, A., Ahmed, S. F., van den, A. E., Blair, J., Bonomi, M., Brachet, C., Broersen, L. H. A., der, G. H. C.-V., Dessens, A. B., Gawlik, A. M., et al. (2022) · Yearbook of pediatric endocrinology · doi:10.1530/ey.19.6.1 · Cited by 1
Uso de inibidores da aromatase para melhora estatural em meninos: uma revisão literária
Cruz, M. O., & Saab, A. R. M. (2023) · Research Society and Development · doi:10.33448/rsd-v12i2.40181 · Cited by 1
Ye, R., Dai, J., & Huang, Y. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0293 · Cited by 2
Dörr, H. (2010) · Elsevier eBooks · doi:10.1016/b978-3-437-24680-7.10030-3 · Cited by 1
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-1 · Cited by 1
Neue Behandlungsstrategien bei adrenogenitalem Syndrom/21‑Hydroxylase-Mangel
Riedl, S. (2022) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-022-00159-y · Cited by 1
Desafios no manejo da hiperplasia adrenal congênita causada pela deficiência da 21-hidroxilase
Alves, C. (2007) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822007000300001 · Cited by 1
Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Lee, P. A., Fuqua, J. S., & Nebesio, T. D. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/276843 · Cited by 1
The Cost of Non-Compliance in Congenital Adrenal Hyperplasia
Zadik, Z. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.12.1093 · Cited by 1
Balbi, V. A., Fernández, V. G., Santucci, Z., & Apezteguía, M. (2002) · Cited by 1
DiMartino-Nardi, J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-156-5_14
Novas perspectivas no tratamento da hiperplasia adrenal congênita
Faria, J. A. D., Sampaio, D. S., Oliveira, L. M. B., Lago, R., Silva, C. N., Canguçú-Campinho, A. K., Schleu, M. F., & Toralles, M. B. P. (2010) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v9i3.5168
Hiperplasia suprarrenal congénita: formas precoces
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Touraine, P. A., & Polak, M. (2010) · EMC - Pediatría · doi:10.1016/s1245-1789(10)70185-2
artigo original Tratamento da Hiperplasia Supra-Renal Congênita por Deficiência da 21-Hidroxilase
Madureira, G., Ueti, R. C., Inácio, M., Silva, F. A. Q., & Mendonca, B. B. (2001)
Caldato, M. C. F., Fernandes, V. T., & Kater, C. E. (2004)
Aromatase Inhibitors and Growth Disorders
Dunkel, L., & Hero, M. T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_116
Panarotto, D., Franciosi, F. S., & Ricci, G. (2006) · Rev. AMRIGS
Konjenital Adrenal Hiperplazi CONGENITAL ADRENAL HYPERPLASIA: MEDICAL EDUCATION
Ba, N., & Tütüncü, Ç. (2007)
New therapies for congenital adrenal hyperplasia
Speiser, P. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200302000-00005
Stein, M. F. R., Wherrett, D. K., Daneman, D., & in collaboration with the Canadian Pediatric Endocrine Group (2005) · Paediatrics & Child Health · doi:10.1093/pch/10.6.323
Congenital adrenal hyperplasia
Daily, J. G., & Vigersky, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00040-1
Debates and Controversies in Genetic Steroid Disorders
Speiser, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00030-2
Adjuvant Chemotherapy and Hormonal Therapy
Thakar, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45343-9_19
Dörr, H. G. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50270-3
Зелінська, Н. Б. (2019) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
Congenital Adrenal Hyperplasia
Baquero, J. A. G., & Vigersky, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05885-8.00031-3
Berberoğlu, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_3
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_13
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_59
21-Hydroxylase Deficiency: Clinical and Biochemical Aspects
Nordenström, A., & Lajić, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65208-x
Congenital adrenal hyperplasia in children
Riepe, F. G. (2011) · doi:10.1093/med/9780199235292.003.7122
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-2
Debates and controversies in genetic steroid disorders
Speiser, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00014-9
Adrenal Multidisipliner Güncel Yaklaşım
Özen, F. Z., Özer, M., Özsoy, Ç., Binnetoğlu, E., Alparslan, A. Ş., Budak, E. S., Kök, E. V., Çetinkaya, G. S., Durmuş, M. E., Köker, G., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2992
21-Hydroxylase deficiency: Clinical and biochemical aspects
Nordenström, A., & Lajić, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00171-0
Chong, H., Pi, Y., Zhang, Y., Li, Y., Xing, Y., & Zhang, H. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05643-3
Hyperplasie congénitale des surrénales : formes précoces
Levaillant, L., Bouhours‐Nouet, N., Rouleau, S., Amsellem‐Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(25)85172-x
Peripheral Precocious Puberty: Interventions to Improve Growth
Haddad, N. G., & Eugster, E. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_71
Hiperplasia suprarrenal congénita: formas precoces
Levaillant, L., Bouhours-Nouet, N., Rouleau, S., Amsellem-Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pediatría · doi:10.1016/s1245-1789(25)51124-1
de la Perrière, A. B., & Martinerie, L. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.01.004
Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia
Goai, W. H., & Torpy, D. J. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2695099
Çelik, N. B., Şenkalfa, B., Vurallı, D., Özön, Z. A., & Gonc, E. N. (2026) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1829514
The evolution of new approaches to the treatment of congenital adrenal hyperplasia
Merke, D. P., & Auchus, R. J. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag033
Self-citationSzklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
Metadata
- Authors
- Merke, D. P., Keil, M. F., Jones, J. V., Fields, J., Hill, S., & Cutler, G. B.
- Affiliations
- Warren Grant Magnuson Clinical Center (D.P.M., S.H.), Bethesda, Maryland 20892
- Developmental Endocrinology Branch (D.P.M., M.F.K., J.V.J., J.F., G.B.C.), Bethesda, Maryland 20892
- National Institutes of Health (US)
- Corresponding author
- Merke, Deborah P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-03-01
- Volume
- 85
- Issue
- 3
- Pages
- 1114-1120
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1997037606
- Cited by
- 190
- References
- 28
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 10 · 2021: 5 · 2020: 5 · 2019: 9 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 9 · 2014: 3 · 2013: 6 · 2012: 2
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- congenital adrenal hyperplasia, flutamide, testolactone, fludrocortisone, hyperandrogenism, linear growth velocity, skeletal maturation, glucocorticoid excess, 17-hydroxyprogesterone, androgen to estrogen conversion, pediatric endocrinology
- MeSH terms
- Adrenal Hyperplasia, Congenital, Androgen Antagonists, Androgens, Anti-Inflammatory Agents, Bone Development, Child, Child, Preschool, Female, Flutamide, Follow-Up Studies, Growth, Hormones, Humans, Hydrocortisone, Male, Testolactone, Weight Gain, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
